These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 32896549)

  • 1. The cannabinoid CB
    Iyer V; Slivicki RA; Thomaz AC; Crystal JD; Mackie K; Hohmann AG
    Eur J Pharmacol; 2020 Nov; 886():173544. PubMed ID: 32896549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slowly Signaling G Protein-Biased CB
    Lin X; Dhopeshwarkar AS; Huibregtse M; Mackie K; Hohmann AG
    Mol Pharmacol; 2018 Feb; 93(2):49-62. PubMed ID: 29192123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid CB
    Guenther KG; Lin X; Xu Z; Makriyannis A; Romero J; Hillard CJ; Mackie K; Hohmann AG
    Biomed Pharmacother; 2024 Jul; 176():116879. PubMed ID: 38850666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid CB
    Zavala CA; Thomaz AC; Iyer V; Mackie K; Hohmann AG
    Cannabis Cannabinoid Res; 2021 Oct; 6(5):389-400. PubMed ID: 33998863
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal.
    Deng L; Guindon J; Cornett BL; Makriyannis A; Mackie K; Hohmann AG
    Biol Psychiatry; 2015 Mar; 77(5):475-87. PubMed ID: 24853387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-Permeant and -Impermeant Inhibitors of Fatty Acid Amide Hydrolase Synergize with the Opioid Analgesic Morphine to Suppress Chemotherapy-Induced Neuropathic Nociception Without Enhancing Effects of Morphine on Gastrointestinal Transit.
    Slivicki RA; Saberi SA; Iyer V; Vemuri VK; Makriyannis A; Hohmann AG
    J Pharmacol Exp Ther; 2018 Dec; 367(3):551-563. PubMed ID: 30275151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid CB2 Agonist AM1710 Differentially Suppresses Distinct Pathological Pain States and Attenuates Morphine Tolerance and Withdrawal.
    Li AL; Lin X; Dhopeshwarkar AS; Thomaz AC; Carey LM; Liu Y; Nikas SP; Makriyannis A; Mackie K; Hohmann AG
    Mol Pharmacol; 2019 Feb; 95(2):155-168. PubMed ID: 30504240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists.
    Grenald SA; Young MA; Wang Y; Ossipov MH; Ibrahim MM; Largent-Milnes TM; Vanderah TW
    Neuropharmacology; 2017 Apr; 116():59-70. PubMed ID: 28007501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditional deletion of CB2 cannabinoid receptors from peripheral sensory neurons eliminates CB2-mediated antinociceptive efficacy in a mouse model of carrageenan-induced inflammatory pain.
    Guenther KG; Xu Z; Romero J; Hillard CJ; Mackie K; Hohmann AG
    Neuropharmacology; 2023 Oct; 237():109601. PubMed ID: 37286073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid CB
    Guenther KG; Lin X; Xu Z; Makriyannis A; Romero J; Hillard CJ; Mackie K; Hohmann AG
    bioRxiv; 2024 Mar; ():. PubMed ID: 38496640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral sensory neuron CB2 cannabinoid receptors are necessary for both CB2-mediated antinociceptive efficacy and sparing of morphine tolerance in a mouse model of anti-retroviral toxic neuropathy.
    Carey LM; Xu Z; Rajic G; Makriyannis A; Romero J; Hillard C; Mackie K; Hohmann AG
    Pharmacol Res; 2023 Jan; 187():106560. PubMed ID: 36417942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive Allosteric Modulation of CB
    Slivicki RA; Iyer V; Mali SS; Garai S; Thakur GA; Crystal JD; Hohmann AG
    Front Mol Neurosci; 2020; 13():54. PubMed ID: 32410959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CB1 Knockout Mice Unveil Sustained CB2-Mediated Antiallodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain.
    Deng L; Cornett BL; Mackie K; Hohmann AG
    Mol Pharmacol; 2015 Jul; 88(1):64-74. PubMed ID: 25904556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence.
    Slivicki RA; Xu Z; Kulkarni PM; Pertwee RG; Mackie K; Thakur GA; Hohmann AG
    Biol Psychiatry; 2018 Nov; 84(10):722-733. PubMed ID: 28823711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A peripheral CB2 cannabinoid receptor mechanism suppresses chemotherapy-induced peripheral neuropathy: evidence from a CB2 reporter mouse.
    Lin X; Xu Z; Carey L; Romero J; Makriyannis A; Hillard CJ; Ruggiero E; Dockum M; Houk G; Mackie K; Albrecht PJ; Rice FL; Hohmann AG
    Pain; 2022 May; 163(5):834-851. PubMed ID: 35001054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative allosteric modulation of CB
    Iyer V; Saberi SA; Pacheco R; Sizemore EF; Stockman S; Kulkarni A; Cantwell L; Thakur GA; Hohmann AG
    Neuropharmacology; 2024 Oct; 257():110052. PubMed ID: 38936657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-nociceptive interactions between opioids and a cannabinoid receptor 2 agonist in inflammatory pain.
    Yuill MB; Hale DE; Guindon J; Morgan DJ
    Mol Pain; 2017; 13():1744806917728227. PubMed ID: 28879802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro.
    Slivicki RA; Xu Z; Mali SS; Hohmann AG
    Pharmacol Res; 2019 Apr; 142():267-282. PubMed ID: 30739035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid CB
    Li AL; Carey LM; Mackie K; Hohmann AG
    J Pharmacol Exp Ther; 2017 Aug; 362(2):296-305. PubMed ID: 28592614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice.
    Wilkerson JL; Ghosh S; Mustafa M; Abdullah RA; Niphakis MJ; Cabrera R; Maldonado RL; Cravatt BF; Lichtman AH
    Neuropharmacology; 2017 Mar; 114():156-167. PubMed ID: 27890602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.